Table 2.
Differences in Percent Adherence in 24 Months After ART Initiation by Race/Ethnicity
| Adherencea | (95% CI) | ||
|---|---|---|---|
| Unadjusted | |||
| Black (ref=White) | −4.6% | (−6.5, −2.7) | <0.001 |
| Hispanic (ref=White) | −1.7% | (−3.9, 0.5) | 0.13 |
| Adjustedb | |||
| Black (ref=White) | −5.8% | (−8.1, −3.6) | <0.001 |
| Hispanic (ref=White) | −4.9% | (−7.3, −2.5) | <0.001 |
| Male sex | 4.2% | (1.2, 7.2) | 0.006 |
| Age (10 years) | 2.9% | (1.9, 3.8) | <0.001 |
| Year ART initiation (1 yr) | 1.4% | (1.1, 1.8) | <0.001 |
| Not MSM | −0.6% | (−2.6, 1.3) | 0.53 |
| Low education census tract | −1.3% | (−3.4, 0.8) | 0.21 |
| Low income census tract | −0.8% | (−3.2, 1.6) | 0.52 |
| Public health insurance | −4.8% | (−7.7, −2.0) | <0.001 |
| Pre-ART CD4 (100 cells) | 0.3% | (−0.2, 0.7) | 0.24 |
| Pre-ART HIV RNA (1 log) | −1.1% | (−2.1, 0.0) | 0.04 |
| Prior ART experience | −8.2% | (−10.3, −6.2) | <0.001 |
| PI-sparing ART class | 4.2% | (2.4, 6.1) | <0.001 |
| Hepatitis C co-infection | −5.7% | (−8.0, −3.4) | <0.001 |
| Depression diagnosis | −2.0% | (−4.1, 0.0) | 0.06 |
| Charlson scorec 1–2 (ref = 0) | −0.8% | (−3.0, 1.3) | 0.45 |
| Charlson scorec ≥3 (ref = 0) | −5.3% | (−12.8, 2.2) | 0.17 |
antiretroviral therapy, confidence interval, hazard ratio, men who have sex with men, protease inhibitor
a Difference in % adherence compared with reference group.
b Multivariable model includes all parameters listed.
c Modified Charlson comorbidity index which excludes HIV or AIDS-related outcomes.